4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001933414-24-000052
Chief Medical Officer sold 25,482 shares at $15.03 ($383,066)
- Chief Medical Officer acquired 25,482 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rodman David Malcom Chief Medical Officer | 2024-11-06 | Option exercise 10b5-1 | +25,482 | $1.08 | $27,521 | 161,456 | D |
| Rodman David Malcom Chief Medical Officer | 2024-11-06 | Sale 10b5-1 | −25,482 | $15.03 | $383,066 | 135,974 | D |
| Derivatives | |||||||
| Rodman David Malcom Chief Medical Officer | 2024-11-06 | Option exercise · Stock Option 10b5-1 | −25,482 | 139,952 | D | ||
| Open-market sales · 25,482 sh · avg $15.03 · $383,066 | |||||||
Loading xslF345X05/wk-form4_1731100892.xml…